SCHEMBL8691838

SCHEMBL8691838

CCC(=O)NCC(Cl)N1CCCC(OCc2ccccc2)C1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ BCHE P06276 5/20 0.40
▸ LMNA P02545 2/20 0.39
▸ ALDH1A1 P00352 2/20 0.39
▸ MAPK1 P28482 1/20 0.39
▸ GPR119 Q8TDV5 1/20 0.39
▸ MAOB P27338 2/20 0.39
▸ P2RX7 Q99572 2/20 0.39
▸ CHRM2 P08172 1/20 0.38
▸ CHRM1 P11229 1/20 0.38
▸ CHRM3 P20309 1/20 0.38
▸ DRD2 P14416 1/20 0.38
▸ DRD3 P35462 1/20 0.38
▸ KCNH2 Q12809 1/20 0.38
▸ TMEM97 Q5BJF2 1/20 0.38
▸ CARM1 Q86X55 1/20 0.38
▸ PRMT6 Q96LA8 1/20 0.38
▸ SIGMAR1 Q99720 1/20 0.38
▸ PRMT8 Q9NR22 1/20 0.38
▸ HRH3 Q9Y5N1 1/20 0.38
▸ KMT2A Q03164 2/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27741091 0.74 CHRM2 (0.42) BCHELMNAALDH1A1MAPK1MAOB
SCHEMBL11175416 0.70 MAPK1 (0.48) BCHELMNAALDH1A1MAPK1CHRM2
SCHEMBL29117240 0.70 CTSL (0.49) BCHELMNAALDH1A1MAPK1MAOB
SCHEMBL29117236 0.70 CTSL (0.49) BCHELMNAALDH1A1MAPK1MAOB
SCHEMBL29117319 0.68 PRMT5 (0.56) GPR119
SCHEMBL12607070 0.68 PRMT5 (0.56) GPR119
SCHEMBL12607067 0.68 PRMT5 (0.56) GPR119
SCHEMBL14047773 0.68 CHRM2 (0.71) LMNAALDH1A1MAPK1CHRM2CHRM1
SCHEMBL27741092 0.68 DRD2 (0.50) BCHELMNAALDH1A1MAPK1MAOB
SCHEMBL2977297 0.67 MEN1 (0.55) BCHEALDH1A1KMT2AGAARAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5750536-A ANTI-ASTHMATICS, TREATMENT OF PAIN SENSITIVITY DOMPE ' SPA (IT) 1998-05-12 — — US disclosed
Send feedback